Correspondence 0001104659-23-094478 from Outlook Therapeutics, Inc. (OTLK)
Outlook Therapeutics, Inc.
Date: Aug. 23, 2023 · CIK: 0001649989 · Accession: 0001104659-23-094478
AI Filing Summary & Sentiment
File numbers found in text: 333-273979
Letter
OUTLOOK THERAPEUTICS, INC.
485 Route 1 South
Building F, Suite 320
Iselin, New Jersey 08830
(609) 619-3990
August 23, 2023
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Re: Outlook Therapeutics, Inc.
Registration Statement on Form S-3
Filed August 14, 2023
File No. 333-273979
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-3 (File No. 333-273979) (the “Registration Statement”) to become effective on Thursday, August 25, 2023, at 4:00 p.m., Eastern Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby authorizes Yvan-Claude Pierre of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Yvan-Claude Pierre of Cooley LLP, counsel to the Registrant, at (212) 479-6721, or in his absence Courtney Tygesson of Cooley LLP at (312) 881-6680.
Very truly yours,
OUTLOOK THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm OUTLOOK THERAPEUTICS, INC. 485 Route 1 South Building F, Suite 320 Iselin, New Jersey 08830 (609) 619-3990 August 23, 2023 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Re: Outlook Therapeutics, Inc. Registration Statement on Form S-3 Filed August 14, 2023 File No. 333-273979 Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-3 (File No. 333-273979) (the “Registration Statement”) to become effective on Thursday, August 25, 2023, at 4:00 p.m., Eastern Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby authorizes Yvan-Claude Pierre of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Yvan-Claude Pierre of Cooley LLP, counsel to the Registrant, at (212) 479-6721, or in his absence Courtney Tygesson of Cooley LLP at (312) 881-6680. Very truly yours, OUTLOOK THERAPEUTICS, INC. By: Name: Lawrence A. Kenyon Title: Chief Financial Officer, Treasurer and Secretary cc: Yvan-Claude Pierre, Cooley LLP Courtney Tygesson, Cooley LLP